0000899243-23-012027.txt : 20230502
0000899243-23-012027.hdr.sgml : 20230502
20230502195332
ACCESSION NUMBER: 0000899243-23-012027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230502
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klapstein Julie D
CENTRAL INDEX KEY: 0001518668
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39427
FILM NUMBER: 23881220
MAIL ADDRESS:
STREET 1: 1239 FRUIT COVE ROAD NORTH
CITY: JACKSONVILLE
STATE: FL
ZIP: 32259
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oak Street Health, Inc.
CENTRAL INDEX KEY: 0001564406
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
IRS NUMBER: 843446686
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 W. MONROE ST., STE. 1200
CITY: CHICAGO
STATE: IL
ZIP: 60603
BUSINESS PHONE: 312-773-3374
MAIL ADDRESS:
STREET 1: 30 W. MONROE ST., STE. 1200
CITY: CHICAGO
STATE: IL
ZIP: 60603
FORMER COMPANY:
FORMER CONFORMED NAME: Oak Street Health, LLC
DATE OF NAME CHANGE: 20121211
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-02
1
0001564406
Oak Street Health, Inc.
OSH
0001518668
Klapstein Julie D
C/O OAK STREET HEALTH, INC.
30 W. MONROE STREET, SUITE 1200
CHICAGO
IL
60603
1
0
0
0
0
Common stock, $0.001 par value
2023-05-02
4
D
0
31684
39.00
D
0
D
Pursuant to that certain Agreement and Plan of Merger, dated as of February 7, 2023 (the "Merger Agreement"), by and among the Issuer, CVS Pharmacy, Inc. ("Parent"), Halo Merger Sub Corp. ("Merger Sub") and, for the limited purposes set forth therein, CVS Health Corporation, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $39.00 per share in cash, without interest and subject to applicable tax withholdings (the "Per Share Price").
(Continued from Footnote 1) The shares of the Issuer's common stock reported as disposed by the Reporting Person include vested restricted stock units ("RSUs") of the Issuer which, pursuant to the Merger Agreement, were, at the Effective Time, automatically canceled and converted into the right to receive an amount in cash (without interest and subject to applicable tax withholdings) equal to the product of the Per Share Price multiplied by the number of shares of the Issuer's common stock subject to such RSUs as of immediately prior to the Effective Time.
The shares of the Issuer's common stock reported as disposed on this Form 4 reflects a correction to the Reporting Person's Form 4 filed on April 25, 2023, which incorrectly reported 50,912 shares of the Issuer's common stock as beneficially owned by the Reporting Person following the reported transaction instead of the correct amount of 31,684 shares of the Issuer's common stock.
/s/ Robert Guenthner, attorney-in-fact for Julie Klapstein
2023-05-02